Vaccine trials are designed to encounter infections among participants | The Hindu In Focus podcast
In this first of two episodes on COVID-19 vaccines, we give you a quick explainer on what to expect from vaccine trials and how to interpret news around it. Concerns have risen around Bharat Biotech\u2019s vaccine candidate after Haryana Health Minister Anil Vij, who participated as a volunteer in the phase 3 trials for Covaxin, tested positive for COVID-19 two weeks after receiving the shot.\nAs more vaccine candidates emerge, we are likely to hear of more such incidents. But it is important to remember, as we learn in this episode, that infections arising among some participants is actually part of the clinical trial design for most vaccines.\nGuest: Jacob Koshy, Deputy Science Editor, The Hindu.\nCoronavirus | About 130 Covaxin trial volunteers may test positive, says Bharat Biotech\nFind the In Focus podcast on Spotify, Apple Podcasts and Stitcher. Search for \u2018In Focus by The Hindu\u2019.\nWrite to us with comments and feedback at socmed4@thehindu.co.in.